Is MEDVi the Top GLP-1 Provider for 2026? Platform Offers Compounded Semaglutide at $179/Month Without a Contract Before Weight Loss Season

Telehealth Platform Overview: MEDVi offers compounded GLP-1 injections and oral tablets at a lower cost compared to FDA-approved alternatives, with prices starting at $179 for the first month and $299 for refills, targeting consumers seeking affordable weight loss solutions as the New Year approaches.

Operational Structure: The platform operates through a three-entity model involving MEDVi for technology, OpenLoop Health for medical evaluations, and partner compounding pharmacies for medication fulfillment, emphasizing that MEDVi does not provide healthcare services directly.

Regulatory Considerations: Compounded medications offered by MEDVi are not FDA-approved, and patients are advised to consult healthcare professionals before starting treatment, as these medications may carry different safety and efficacy profiles compared to FDA-approved options.

Market Dynamics: The demand for compounded GLP-1 medications is rising due to limited insurance coverage for weight loss drugs and high retail prices of FDA-approved medications, with MEDVi positioning itself as a more accessible alternative in the telehealth landscape.